Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, Medfirst Healthcare Services's highest 3-Year average EPS without NRI Growth Rate was 43.40% per year. The lowest was -26.40% per year. And the median was -0.30% per year.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Medfirst Healthcare Services EPS (Diluted) Related Terms
Medfirst Healthcare Services EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Medfirst Healthcare Services's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medfirst Healthcare Services PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medfirst Healthcare Services's PE Ratio distribution charts can be found below:
* The bar in red indicates where Medfirst Healthcare Services's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medfirst Healthcare Services (ROCO:4175) has a EPS (Diluted) of NT$3.64 as of Dec. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Medfirst Healthcare Services and its competitors.
Is Medfirst Healthcare Services' EPS (Diluted) too high?
Medfirst Healthcare Services' current EPS (Diluted) is NT$3.64. Overall, Medfirst Healthcare Services has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medfirst Healthcare Services' EPS (Diluted) compare to competitors?
Medfirst Healthcare Services' EPS (Diluted) of NT$3.64 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Healthcare Providers & Services company?
A good EPS (Diluted) depends on the Healthcare Providers & Services industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Medfirst Healthcare Services and its competitors. Medfirst Healthcare Services's current EPS (Diluted) is NT$3.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medfirst Healthcare Services stock overvalued right now?
Based on GuruFocus' analysis, Medfirst Healthcare Services (ROCO:4175) is currently considered Possible Value Trap. The stock's GF Value™ is NT$74.49, compared to a current price of NT$50.20 — trading 32.6% below its estimated fair value. The current EPS (Diluted) is NT$3.64. Medfirst Healthcare Services' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Medfirst Healthcare Services (ROCO:4175), the current EPS (Diluted) is NT$3.64 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medfirst Healthcare Services (ROCO:4175) Overvalued in 2026?
Based on GuruFocus' analysis, Medfirst Healthcare Services stock appears to be undervalued.
The current stock price of NT$50.20 is trading 32.6% below its estimated GF Value™ of NT$74.49.
GuruFocus considers Medfirst Healthcare Services to be Possible Value Trap.
Key valuation signals for ROCO:4175:
EPS (Diluted): NT$3.64
GF Value™: NT$74.49 vs. price of NT$50.20 (32.6% below fair value)
No single metric tells the full story. See the ROCO:4175 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medfirst Healthcare Services Inc is mainly engaged in the sale of medical supplies and the management of shopping malls. The company's geographical segment includes Mainland China and Taiwan. It generates maximum revenue from Taiwan. The company derives a majority of its revenue from medical care products followed by health care.
68GF Score
Get the complete analysis for ROCO:4175
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4175 has been successfully added to your 
